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Abstract
Background: Almost 50% of pregnancies in the United States are unwanted or mistimed. Notably, just over
one-half of unintended pregnancies occurred when birth control was being used, suggesting inappropriate or poor
use or contraceptive failure. About two-thirds of all women who are of reproductive age use contraceptives, and
oral hormonal contraceptives remain the most common contraceptive method. Often, contraceptive products are
obtained in community pharmacies. The purpose of this study was to determine whether a pharmacy-based
intervention would impact sales of contraceptive products in pharmacies.
Methods: This study was conducted in Iowa and used a quasi-experimental design including 55 community
pharmacies (independent and grocery) in 12 counties as the intervention and 32 grocery pharmacies in 10 counties
as a comparison group. The passive intervention was focused towards 18–30 year old women who visited community
pharmacies and prompted those of childbearing age to “plan your pregnancy” and “consider using birth control”. The
intervention was delivered via educational tri-fold brochures, posters and ‘shelf talkers.’ Data sources for evaluation were
contraceptive sales from intervention and comparison pharmacies, and a mixed negative binomial regression was used
with study group*time interactions to examine the impact of the intervention on oral contraceptive and condom sales.
Data from 2009 were considered baseline sales.
Results: From 2009 to 2011, condom sales decreased over time and oral contraceptives sales showed no change.
Overall, the units sold were significantly higher in grocery pharmacies than in independent pharmacies for both
contraceptive types. In the negative binomial regression for condoms, there was an overall significant interaction
between the study group and time variables (p = 0.003), indicating an effect of the intervention, and there was a
significant slowing in the drop of sales at time 3 in comparison with time 1 (p < 0.001). There was a statistically
significant association between pharmacy type and study group, where the independent intervention pharmacies had
a higher proportion of stores with increases in condom sales compared to grocery pharmacies in the intervention or
comparison group.
Conclusions: A passive community pharmacy-based public health intervention appeared to reduce the decrease in
condom sales from baseline, particularly in independent pharmacies, but it did not impact oral contraceptive sales.
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Background
Almost 50% of pregnancies in the United States are un-
wanted or mistimed [1]. Women who are poor, age 18–24,
cohabiting and minority are more likely to experience
unintended pregnancies [1]. Unintended pregnancy is
associated with delayed prenatal care and poor out-
comes [2-4]. Evidence suggests that reducing risky be-
havior, promoting use of effective contraception and
improving appropriate use of all contraceptive methods
remain important public health goals. Notably, just over
one-half of unintended pregnancies occurred when
birth control was being used [5].
In the United States, about two-thirds of all women who
are of reproductive age use contraceptives, and oral con-
traceptives remain the most common hormonal method
of contraception [2]. In 2010, oral contraceptives and fe-
male sterilization were the two most common contracep-
tive methods among women who practiced contraception
in the U.S., and this has been true since 1982 [6,7]. Among
all U.S. women 15–44 years old who practice contracep-
tion, 17% use oral contraceptives, 3.5% use an intrauterine
device, 2.4% use a hormonal injectable, 1.3% use a vaginal
ring and < 0.5% use either patch or implant [7].
Often, prescription or nonprescription contraceptive
products, primarily hormonal methods, are obtained in
community pharmacies. In the United States, oral con-
traceptives, contraceptive patches, vaginal rings and
contraceptive injections are available via prescription in
pharmacies, yet oral contraceptives are the most widely
used product. Condoms and spermicides are available
over-the-counter, and condoms are widely available in
other types of retail outlets. At the time of this study,
emergency contraception was available in pharmacies
from behind the counter, requiring pharmacists to counsel
about its use.
Farris et al. outlined roles of pharmacists in reducing
unintended pregnancy, yet pharmacists typically dispense
and sell contraceptive products with little additional inter-
action with consumers/patients [8]. In terms of emergency
contraception, access has been an issue with some phar-
macists refusing to sell it, although attitudes seemed to
have improved since the early 2000s [8,9]. Over the past
two decades, laws in states have taken various strategies to
address access to contraceptives from requiring pharma-
cies to fill all valid prescriptions to expressly allowing
pharmacists to refuse to dispense emergency contracep-
tion [10]. Admittedly, contraception in the United States
is considered by some to be an ethical issue, and some
pharmacists do refuse to dispense contraceptives and sell
emergency contraceptives [10].
The vast majority of pharmacists and pharmacies may
be a valuable non-traditional venue for disseminating
information about improving effective contraceptive use
and reducing unintended pregnancy [8,9,11-15]. In fact,
pharmacists are considered an accessible healthcare pro-
vider because they are well-trained, available in rural
areas and do not typically require appointments. Phar-
macies and pharmacists have not capitalized upon this
potential role, although patient-oriented practices are
discussed widely in the pharmacy literature [14-18].
We are aware of no other study using a social marketing
approach in community pharmacies to impact contracep-
tive sales [8,15]. Previous studies in pharmacy have pri-
marily focused on access to emergency contraception. In
addition, progesterone injections have been administered
in pharmacies. Finally, new models of contraceptive deliv-
ery have been tested, whereby pharmacists working under
collaborative practice agreements are able to prescribe
hormonal contraceptives [19,20]. In fact, the American
College of Clinical Pharmacy Women’s Health Practice
and Research Network advocates changing the status of
oral contraceptives from prescription to over-the-counter
status in licensed pharmacies while a pharmacist is on
duty [15].
Because of their potential public health role, commu-
nity pharmacies were one component of the Iowa Initia-
tive to Reduce Unintended Pregnancies active in Iowa
from 2007–2012. The overall program sought to use
policy, access to healthcare services including long-
acting reversible contraceptives and research interven-
tions to impact the rate of unintended pregnancy in the
state [21]. There were five research interventions exam-
ined in the program, all focused to persuade adult
women 18–30 years old to seek and purchase contracep-
tives, particularly long-acting reversible contraceptives, if
they wished to delay or prevent pregnancy. Across Iowa,
there were about 183,000 women age 15–29 requiring
contraceptives [22]. One of the five interventions was
in the community pharmacy, a non-traditional avenue
for public health initiatives. The purpose of this analysis
was to determine whether a pharmacy-based interven-




We used a quasi-experimental observational design to
evaluate the intervention in Iowa pharmacies. This study
was approved by the Institutional Review Boards at the
University of Northern Iowa, University of Iowa and
University of Michigan. Sixty pharmacies began the
intervention that ran from Fall 2009 to Fall 2011. We
fully implemented the intervention in 55 community
pharmacies in 12 counties, and the pharmacies were
either independently owned or located inside a mid-
western grocery chain. We were able to recruit in speci-
fied counties established by the larger Iowa Initiative
project, and we included those counties where we were
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able to recruit at least 25% of pharmacies. The pharma-
cies were recruited using an introductory letter, tele-
phone contact and visit by study personnel, typically one
of the co-principal investigators. Early in 2010, two phar-
macies withdrew citing the amount of time to participate
and three withdrew due to a customer complaint regard-
ing the subject matter. We identified 10 counties in Iowa
with similar demographics to counties where the inter-
vention pharmacies resided. We identified 32 pharma-
cies in the same grocery chain in those 10 counties, and
these pharmacies served as a comparison group. These
control counties provided a means to monitor the im-
pact of the other Iowa Initiatives on pharmacy contra-
ceptive sales and to easily gather sales data.
Based on our initial survey of Iowa pharmacies, pharma-
cies in Iowa dispensed an average of 201 prescriptions per
day but the range was broad (standard deviation was 100).
On average they employed 1.67 (s.d. 0.77) pharmacists
and 2.44 (s.d. 1.47) pharmacy technicians. Independent
pharmacies compared to grocery pharmacies tended to be
more likely to have a private area to talk with patients, be
less likely to stock male condoms, be more likely to place
male condoms on shelf (not behind locked glass) and be
less likely to dispense emergency contraception [11].
There are 99 counties in Iowa and approximately 700
community pharmacies in the state.
Intervention
The intervention was comprised of seven sets of social-
marketing materials placed in the intervention pharma-
cies at quarterly intervals, and pharmacy staff was aware
of the intervention. The social marketing campaign in
the pharmacies prompted women of childbearing age to
“plan your pregnancy” and “consider using birth con-
trol”. The goal of the intervention in the pharmacy was
to increase the uptake of contraceptive products, and we
measured this potential effect in pharmacies by way of
contraceptive sales. Information was delivered passively
via educational tri-fold brochures, posters and ‘shelf
talkers.’ Each quarter a free product such as lip balm,
pen or chip clip with the study logo was set near the
cash register so that any individual could chose to take
it. The free products, posters and brochures were
branded in a similar manner with the study logo. Mate-
rials were used passively and were not directly distrib-
uted to individuals purchasing contraceptive products.
We chose to use a passive approach because there was
no reimbursement available to sustain pharmacists’ ex-
panded services. Anecdotally, pharmacists told us that
they used the tri-fold brochure explaining hormonal
contraceptives in their patient counseling.
The original social-marketing messages were based upon
a previous campaign called Pharmacy Access Partnership
[23]. For our project, selected materials were reviewed by
seven Iowa community pharmacies in personal interviews,
four focus groups of young adults and an Advisory Board
(for the study) comprised of four community pharmacists
and four young adult female consumers. The study team
reviewed the original marketing materials and developed
new messages, and the Advisory Board reviewed the
final materials. In total, we produced 6 educational
brochures, 7 shelf-talkers and 8 posters (Table 1 and
Figure 1). Examples of messages included “Crossing
your Fingers Won’t Help”, “50% of Pregnancies in Iowa
are Not Planned” and “Did You Know? There Are More
Choices than Pills or Condoms”. Each quarter the mate-
rials were different colors, but all materials during a
quarter used the same color.
Research assistants visited the pharmacies quarterly
and changed the materials. Posters were placed on glass
fronts or walls near the pharmacy department, shelf-
talkers were placed near non-prescription contracep-
tives and educational brochures were placed near
contraceptives, near other brochures or at the pharmacy
cash register. Free products were also placed near the
cash register. Research assistants maintained monthly
contact with the pharmacy staff to ensure sufficient ma-
terials were available. Our research assistants docu-
mented that all free products with the study logo were
distributed, over 600 brochures were distributed and
each intervention pharmacy had posters and/or shelf
talkers posted in their pharmacies each period of the
intervention.
Data sources
The evaluation presented here uses contraceptive sales
data from the intervention and comparison pharmacies.
We gathered attitudinal and experience data from a ran-
dom sample of young Iowa women as well as from a
convenience sample in the intervention pharmacies, but
the sales data allow us to control for the other Iowa Ini-
tiatives activities via the control group, and the sales
data are an objective assessment of the intervention.
We collected data from pharmacies of the sales of all
hormonal contraceptives, but very few sales existed for
products other than oral contraceptive and condoms.
Long-acting reversible contraceptives are typically ob-
tained from physician offices or clinics not pharmacies.
The three time periods of contraceptive sales data cor-
responded to 2009, 2010, and 2011, and 2009 is the
baseline. Using 2009 sales data as the baseline biases
our results towards no effect, given that contraceptive
sales could have been affected by the intervention in the
last quarter of 2009. The grocery store data were col-
lected from November 1 of the year prior to the stated
year until October 31 of the stated year, and these dates
represent less bias. The independent pharmacies had
two different time periods, either the same as the
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Table 1 Social-marketing materials by quarter
Quarter Informational brochures (titles) Shelf talkers (message content) Posters (message content) Give-away
1 and 5 Birth Control Options That
Use Hormones
Crossing Your Fingers Won’t Help Be Smart, Be Prepared, Be Protected Lip balm, Pens
Birth Control Options
Without Hormones
Got Plans? Protect Yourself From STDs Did You Know? 50% of Pregnancies
In Iowa Are Not Planned
Did You Know? A Pharmacist Is Here
To Talk
2 and 6 Condoms Did You Know? STDs Can Last A Lifetime Did You Know? There Are More
Choices Than Pills or Condoms
Hand Sanitizer,
Emery Boards
Talk With Your Partner
About Contraceptives
50% of Pregnancies In Iowa Are
Not Planned
Crossing Your Fingers Won’t Help
3 and 7 Unintended Pregnancy
Can Lead To…
Did You Know? There Are More
Choices Than Pills or Condoms






Be Smart, Be Prepared, Be Protected Plan Ahead. Hope Won’t Help.
4 Condoms 50% of Pregnancies In Iowa Are
Not Planned




Talk With Your Partner
About Contraceptives
Crossing Your Fingers Won’t Help Are You Really Ready?
Figure 1 Selected materials from the pharmacy-based social marketing campaign.
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grocery store or from January 1 to December 31 of the
stated year, and these times varied because of different
recruitment dates into the study (Figure 2).
The contraceptive sales data were count data designating
the number of units sold in each pharmacy for each type
of contraceptive. Several types of contraceptive products
were obtained including condoms, oral contraceptives,
emergency contraceptives, contraceptive patches, vaginal
rings, contraceptive injections, female condoms, and sper-
micides. In the final analysis, condoms and oral contracep-
tives were considered because other sales were too sparse.
The independent pharmacies sent yearly sales from forms
created for hand-entry, and these data were entered into a
spreadsheet and verified for accuracy. The contraceptive
sales data from the grocery pharmacies were obtained from
a central location. For analysis, we also recorded the
county in which the store was located and whether the
pharmacy was grocery or independent. Of the original 93
stores, 6 did not contribute data in the first two time
periods, and 9 did not have data in the third time period,
so the final analysis sample size was n = 84 (Table 2).
Analysis
For descriptive analysis, we used mean and standard de-
viation. To examine whether there was any change in
the intervention pharmacies compared to the compari-
son pharmacies, we used mixed negative binomial re-
gressions for our primary analysis predicting condom
and oral contraceptive sales (separately) blocked at the
county level. The primary test of interest was the inter-
action between the study group (intervention versus
comparison) and the time variable, which were both
fixed effects. The type of pharmacy was adjusted with a
random clustering effect, and the pharmacies were
nested within pharmacy type (grocery or independent.
In addition to testing for the interaction, we assessed the
main effects for the models. We used (mean) interaction
plots for visualization of the main effects and interac-
tions. We used 2010 Census data to create an adjusted
model, which considered median age, percent of females
in the population, percent college educated and the
mean persons per household for each county. Import-
antly, we conducted a separate analysis using grocery
pharmacy data only, and used the same analytic ap-
proach. Our review of the sales data in grocery pharma-
cies indicated a significant drop-off in reported sales, i.e.,
no sales, in nine pharmacies, and we completed our ana-
lysis with and without those pharmacies to test their
presence on any effects. Finally, we examined the num-
ber of pharmacies with negative or positive changes in
sales over time. All analyses were done using SAS or R
statistical software.
Results
Comparing data from the time 1 baseline to times 2 and
3 during the study, overall condom sales decreased over
time and oral contraceptives sales showed no change
(Table 2). At all time periods, the units sold were signifi-
cantly higher in the grocery pharmacies than in the inde-
pendent pharmacies for both contraceptive types (two
sample t-test pcondoms < 0.001, pOC < 0.001). Over the
three-year study, the average number of condoms sold
per grocery pharmacy was 1213 (s.d. 1214) versus 176
(s.d. 555) for independent pharmacies. For oral contra-
ceptives, the means per pharmacy were 1885 (s.d. 1022)
versus 735 (s.d. 622) for 28-day units, respectively.
The negative binomial regression for condoms was
used to examine the impact of the intervention on con-
dom sales by examining the interaction of study group
by time. The interaction between the study group
Figure 2 Timeline of recruitment, intervention and data collection.
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and time was statistically significantly different that zero
(p = 0.003), indicating an effect of the intervention. The
main effects showed that condom sales were lower in
intervention pharmacies than in comparison pharmacies
and decreased over time (Table 3). While condom sales
dropped in both study groups, the rate of decline in the
intervention pharmacies was less steep than in the com-
parison pharmacies. Specifically, at time 2, the difference
in mean sales between intervention and comparison
pharmacies was not significant (p = 0.283). There was,
however significant slowing or decreased slope at time
3 versus time 1 (p < 0.001). This finding is also reflected
in the pairwise interaction between times 2 and 3
(p = 0.020, Figure 3, top graphs). Similar results were
seen for the study group by time interaction in the linear
mixed models (results not shown). When we excluded
the nine pharmacies with no sales toward the end of
the reporting period from the regression, the overall
Table 2 Contraceptive sales for intervention and comparison pharmacies†
Condoms (mean/standard deviation) Oral contraceptives (mean/standard deviation)
Intervention Comparison Intervention Comparison
All Pharmacies
2009 639(997) 1584(1698) 1107(922) 2014(1116)
2010 656(1044) 1282(1390) 1034(816) 1881(1045)
2011 376(476) 666(550) 1120(946) 1984(1046)
Independent Pharmacies Only
2009 186 (516) 0 742(615) 344(NA)
2010 214 (792) 0 686(429) 441(NA)
2011 144 (272) 0 805(801) 461(NA)
Grocery Pharmacies Only
2009 1426(1146) 1635(1700) 1741(1032) 2068(1091)
2010 1423(998) 1324(1393) 1640(974) 1928(1028)
2011 778(491) 687(545) 1667(947) 2033(1025)
†N analyzed for times 1 and 2 and 3 = 84 (intervention = 52 comparison = 32).
Table 3 Contraceptive sales negative binomial regression results by study group and time
Estimate† SE LB UB t P value
Condoms
intervention (vs. comparison) −1.43 0.73 −2.87 0.01 −1.96 0.051
time 2 (vs. 1) −0.05 0.07 −0.20 0.09 −0.74 0.461
time 3 (vs. 1) −0.46 0.07 −0.61 −0.32 −6.42 <.001
time 3 (vs. 2) −0.41 0.07 −0.55 −0.27 −5.69 <.001
intervention * time 2 (vs. 1) 0.16 0.14 −0.13 0.44 1.08 0.283
intervention * time 3 (vs. 1) 0.50 0.14 0.21 0.78 3.42 <.001
intervention * time 3 (vs. 2) 0.34 0.14 0.06 0.62 2.35 0.020
Oral Contraceptives
intervention (vs. comparison) −0.74 0.22 −1.17 −0.32 −3.44 <.001
time 2 (vs. 1) −0.04 0.04 −0.11 0.04 −0.91 0.363
time 3 (vs. 1) 0.01 0.04 −0.07 0.09 0.02 0.842
time 3 (vs. 2) 0.04 0.04 −0.03 0.12 1.11 0.268
intervention * time 2 (vs. 1) 0.06 0.08 −0.10 0.21 0.73 0.465
intervention * time 3 (vs. 1) 0.03 0.08 −0.12 0.19 0.40 0.693
intervention * time 3 (vs. 2) −0.03 0.08 −0.18 0.13 −0.34 0.737
†Main effect and interaction estimates and p values are computed with contrast tests in the regression.
Interaction terms reference category is always control.
LB = Lower Bound, UB = Upper Bound for a 95% Confidence Interval.
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interaction for study group by time remained statistically
significant (p = 0.046), as did the interaction between
times 1 and 3 (p = 0.003) (results not shown).
For oral contraceptives, there was no statistically signifi-
cant overall interaction between study group and time
(p = 0.765, indicating no effect of the intervention on oral
contraceptive sales. The pairwise interactions were also not
significant (Table 3, Figure 3). The study group by time
interaction in the linear mixed models for oral contracep-
tives showed similar results to the negative binomial model
(results not shown). In the adjusted models including four
covariates from Census data, the model interaction results
for study group by time were similar to our previous find-
ings (pcondoms = 0.003, poral contraceptives = 0.765).
We repeated the same analysis using only grocery
pharmacies in the intervention and comparison groups.
In this analysis, there was no statistically significant
interaction between the study group by time variables
for any of the types of contraceptives (Table 4). To gain
another view of the effect of the intervention on condom
sales, we examined the number of pharmacies with de-
creases in condom sales compared to those with in-
creases or no change (Table 5). There was a statistically
significant association between pharmacy type and study
group, and the independent intervention pharmacies
appeared to have a higher proportion of stores with
increases in condom sales compared to grocery pharma-
cies in the intervention or comparison group.
Discussion
This study is among the first to use and evaluate com-
munity pharmacies as a communication channel for
messages encouraging contraceptive use and promoting
planned pregnancies. This study is important to the pub-
lic health literature because of (1) a new communication
channel, (2) positive findings and (3) future possible
partnerships. The results showed that community phar-
macies can be one mechanism for delivering messages
related to using contraceptives. The social marketing
materials placed in the pharmacies were conservative in
Figure 3 Contraceptive sales interaction plots (Mean).
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appearance, passively delivered and modeled after previ-
ous materials. They were reviewed by pharmacists and
the target group and approved by an advisory board.
Using these materials for 7 quarters in 55 pharmacies
from 12 Iowa counties, the intervention was associated
with a decrease in the decline of condom sales, primarily
in independent pharmacies. The results are based on a
strong analytic approach with a comparison group and
controlled for pharmacy type to examine the impact of
the pharmacy social marketing campaign. We also
Table 4 Grocery pharmacy contraceptive sales negative binomial regression results by study group and time
Estimate† SE LB UB t P value
Condom Sales
intervention (vs. comparison) 0.43 0.36 −0.28 1.14 1.21 0.228
time 2 (vs. 1) −0.07 0.06 −0.19 0.05 −1.13 0.263
time 3 (vs. 1) −0.62 0.06 −0.74 −0.50 −10.32 <0.001
time 3 (vs. 2) −0.55 0.06 −0.67 −0.44 −9.19 <0.001
intervention * time 2 (vs. 1) 0.14 0.12 −0.10 0.38 1.15 0.253
intervention * time 3 (vs. 1) 0.19 0.12 −0.05 0.43 1.60 0.113
intervention * time 3 (vs. 2) 0.05 0.12 −0.19 0.29 0.45 0.652
Oral Contraceptive
intervention (vs. comparison) −0.20 0.16 −0.52 0.11 −1.28 0.205
time 2 (vs. 1) −0.07 0.02 −0.10 −0.03 −3.62 <0.001
time 3 (vs. 1) −0.02 0.02 −0.06 0.02 −1.11 0.269
time 3 (vs. 2) 0.05 0.02 0.01 0.08 2.50 0.014
intervention * time 2 (vs. 1) 0.02 0.04 −0.06 0.09 0.42 0.675
intervention * time 3 (vs. 1) −0.01 0.04 −0.08 0.06 −0.25 0.803
intervention * time 3 (vs. 2) −0.02 0.04 −0.10 0.05 −0.67 0.504
†Main effect and interaction estimates and p values are computed with contrast tests in the regression.
Interaction terms reference category is always control.
LB = Lower Bound, UB = Upper Bound for a 95% Confidence Interval.
Table 5 Change in contraceptive sales by time and by pharmacy type (n = 84)
Condoms
time 1-2 total grocery comparison independent intervention grocery intervention
negative 42 20 11 11
positive/zero 42 11 22 8 Χ2 = 6.75, 2df, p = 0.034
time 2-3
negative 62 30 15 17
positive/zero 22 1 18 2 Χ2 = 25.1, 2df, p < 0.001
time 1-3
negative 58 29 12 17
positive/zero 26 2 21 2 Χ2 = 29.3, 2df, p < 0.001
Oral Contraceptives
time 1-2 total grocery comparison independent intervention grocery intervention
negative 56 25 15 16
positive 28 6 18 3 Χ2 = 6.75, 2df, p = 0.034
time 2-3
negative 35 10 17 8
Positive 49 21 16 11 Χ2 = 6.75, 2df, p = 0.034
time 1-3
negative 48 21 16 11
positive 36 10 17 8 Χ2 = 6.75, 2df, p = 0.034
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controlled by age, gender, education and household size
at the county level to control for factors that may differ-
entiate the study groups and be associated with contra-
ceptive use. A sensitivity analysis was also conducted in
regards to data quality.
Stemming the reductions in condom sales in inde-
pendent pharmacies is positive. It is likely that the
messages in the pharmacies prompted individuals to
purchase condoms. The messages may have been easier
to notice in the independent pharmacies where the size
of the pharmacy is smaller and the purchases are more
focused on health products not groceries. It may be that
some pharmacies became more focused on contraceptive
products because of the study, and they began stocking
condoms or offered more options. Admittedly, other
sources of condoms such as convenience stores, mass
merchandise stores and online purchases may be the
likely cause of overall lower condoms sales in pharma-
cies over time. Stemming the decrease in condom sales
in independent pharmacies is an important finding, as
there are over 23,000 such outlets in the United States.
The possibility of extrapolating this finding to chain
pharmacies with over 50,000 outlets is important to con-
sider in future studies.
The lack of impact on oral contraceptives was discour-
aging. It may be that the women in pharmacies who may
have seen the messages were already using oral contra-
ceptives. Alternatively, messages about how to obtain
prescriptions for these products may be necessary.
Targeting some of the materials, e.g., free product or
brochure, to all women age 18–30 may have been more
effective. However, targeting the materials would have
required the pharmacy staff to alter their routine dis-
pensing procedures, and this effect is difficult to achieve.
Another important strategy may be to develop commu-
nity pharmacy practices where women can gain access
to hormonal contraceptives via pharmacist prescribing
under a collaborative practice agreement. A limited
number of pharmacies have experience using collabora-
tive practice agreements to initiate hormonal contracep-
tives and such an approach may increase access to these
products. This approach may be particularly relevant in
rural communities such as those in Iowa included in this
study [19,20].
It is important to note that during 2010 and early
2011, there was an active state-wide social marketing
campaign called “Avoid the Stork” as part of the Iowa
Initiative [24]. The pharmacy social marking campaign
did not link directly to the “Avoid the Stork” campaign.
In addition, there was also a state-wide investment in
making long-acting reversible contraceptives available
through family planning clinics. The overall results from
the Iowa Initiative showed that unintended pregnancy
rates decreased from 47.3% to 40.9% and that intra-
uterine device and implant use increased among Iowa
women from <1% to 7.45 and 6.0%, respectively. The use
of the comparison pharmacy sales data allowed us to
separate the impact of other campaigns on any effect we
saw in the intervention pharmacies [21].
This study serves as a model to involve community
pharmacies in public health campaigns, including those
focused on reducing unintended pregnancy. A limitation
of this study is that national, chain pharmacies did not
participate because either the messages were perceived to
be too sensitive or the companies did not want to share
their sales data. Their lack of participation was disappoint-
ing because all of those pharmacy organizations sold con-
traceptives, and messages about their use in preventing
unintended pregnancy are important to public health.
Their participation in future initiatives should be encour-
aged because the inclusion of the top two pharmacy
chains impacts just over 30% of the prescription market
share. A rationale for participation in such initiatives that
may possibly garner corporate support is to link public
heath campaigns to corporate social responsibility.
Future projects focused on reducing unintended preg-
nancy or other public health issues should consider co-
ordinating messages with community-based initiatives of
public health departments or health systems, and this
coordination might facilitate their effectiveness. In
addition, further testing of the messages and marketing
pieces with the target population may be needed. As
well, involving pharmacy technician and pharmacists
more fully into any future intervention would likely be
necessary if the desire was to create more extensive be-
havior change among pharmacy clients.
This study had limitations. A comparison group was
used but neither the counties nor pharmacies were ran-
domized. Measurement error may have occurred in the
sales data by mistakes in reporting. One sensitivity ana-
lysis accounted for some apparent missing data, and the
analysis showed no effect of excluding these pharmacies
on the results. As stated, only independent and grocery
pharmacies were included in this study, thereby limiting
the generalizability of the findings. Finally, there was no
explicit focus on emergency contraception in this study,
although access to these products and how to use them
are important public health roles for pharmacists.
Conclusions
Contraceptive sales data were used to quantify the im-
pact of a passive social marketing intervention in com-
munity pharmacies before and during the intervention.
While condom sales were decreasing in both study
groups, the intervention appeared to stem the reduction
in sales in the intervention pharmacies, particularly
independent pharmacies. Oral contraceptive sales were
not affected.
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